Related Experiment Video
Updated: Sep 6, 2025

05:19
Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
Published on: December 1, 2023
1.2K
Predictability of combined cataract surgery and trabeculectomy using Barrett Universal Ⅱ formula
Kei Iijima1, Kazutaka Kamiya2, Yoshihiko Iida1
1Department of Ophthalmology, Kitasato University, Sagamihara, Japan.
Plos One
|June 23, 2022
Summary
The Barrett Universal II formula offers more predictable intraocular lens (IOL) power calculations than the SRK/T formula after combined cataract surgery and trabeculectomy. It is less affected by axial length and corneal shape, improving refractive accuracy.
Area of Science:
- Ophthalmology
- Biomedical Engineering
Background:
- Cataract surgery with trabeculectomy presents unique challenges for intraocular lens (IOL) power calculation.
- Accurate IOL power calculation is crucial for achieving desired refractive outcomes post-surgery.
Purpose of the Study:
- To compare the predictability of the Barrett Universal II and SRK/T formulas for IOL power calculation.
- To evaluate the refractive outcomes in eyes undergoing combined cataract surgery and trabeculectomy.
Main Methods:
- Retrospective review of 56 eyes undergoing combined cataract surgery and trabeculectomy.
- IOL power calculations performed using Barrett Universal II and SRK/T formulas.
- Comparison of prediction error, absolute error, and refractive outcomes at 3 months postoperatively.
Main Results:
- The SRK/T formula resulted in significantly more myopic prediction errors compared to the Barrett Universal II formula.
- The Barrett Universal II formula demonstrated significantly smaller absolute errors.
- Prediction errors with the SRK/T formula correlated with axial length and keratometric readings, unlike the Barrett Universal II formula.
Conclusions:
- The Barrett Universal II formula offers superior predictability for IOL power calculation in eyes undergoing combined cataract surgery and trabeculectomy.
- The Barrett Universal II formula is less influenced by axial length and corneal shape, leading to improved refractive accuracy.
- The Barrett Universal II formula is recommended for clinical use to enhance refractive outcomes in these complex cases.
Related Concept Videos
Angle Closure Glaucoma: Treatment
652
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
652
Glaucoma: Overview
727
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
727
Open Angle Glaucoma: Treatment
546
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
546

